Science Explorer Back to mapMap
Discussion
Researcher · Quality Research · United States

Charudharshini Srinivasan

Charudharshini Srinivasan publishes mostly in Molecular Biology, Pharmaceutical Science and Materials Chemistry, on topics such as Protein purification and stability, Drug Solubulity and Delivery Systems and RNA Interference and Gene Delivery.

OpenAlex
World rank
#4,224,172
of 7,710,434 ranked researchers
Rank in United States
#1,139,357
of 1,627,098
Works
28
Citations
499
Citations per work
17.8
h-index
10
i10-index 10Top 76% in Molecular Biology
Charudharshini Srinivasan

What does Charudharshini Srinivasan research?

Charudharshini Srinivasan's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Pharmacology, Toxicology and Pharmaceutics (14%), Engineering (12%).

Life Sciences: 11 works · 41.0% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 26.9% of their workMolecular Biology: 6 works · 23.1% of their workBiophysics: 1 works · 3.8% of their workPharmacology, Toxicology and Pharmaceutics: 4 works · 14.1% of their workPharmaceutical Science: 4 works · 14.1% of their workEverything else: 11 works · 39.8% of their workPhysical Sciences: 5 works · 19.2% of their workEngineering: 3 works · 11.5% of their workBiomedical Engineering: 2 works · 7.7% of their workMechanical Engineering: 1 works · 3.8% of their workMaterials Science: 2 works · 7.7% of their workMaterials Chemistry: 2 works · 7.7% of their workTHEIR WORKCharudharshiniSrinivasan28works
Life Sciences41%Physical Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology826.9%
    2. Pharmacology, Toxicology and Pharmaceutics414.1%
  2. Everything else1139.8%
    1. Engineering311.5%
    2. Materials Science27.7%
  1. 1Molecular Biology23% of their works
  2. 2Pharmaceutical Science14% of their works
  3. 3Materials Chemistry8% of their works
  4. 4Biomedical Engineering8% of their works
  5. 5Biophysics4% of their works
  6. 6Mechanical Engineering4% of their works

Research topics

Which keywords describe Charudharshini Srinivasan's research?

The keywords of their largest research topics: Nanoparticles, Biopharmaceuticals, Protein Aggregation, Cyclodextrins, Gene Therapy, Solid Dispersions, Chitosan and Mucosal.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Nanoparticles103 topics
  2. Biopharmaceuticals81 topic
  3. Protein Aggregation81 topic
  4. Cyclodextrins61 topic
  5. Gene Therapy62 topics
  6. Solid Dispersions61 topic
  7. Chitosan41 topic
  8. Mucosal41 topic
  9. RNA Interference41 topic
  10. siRNA Delivery41 topic
  11. DNA nanotechnology31 topic
  12. Nanoemulsions31 topic
  13. Proteins31 topic
  14. Self-Assembly31 topic
  15. AAV21 topic
  16. Bioimage Analysis21 topic
  17. High-Content Screening21 topic
  18. Viral Vectors21 topic

Where does Charudharshini Srinivasan work?

Charudharshini Srinivasan's main affiliation in the publication record is Quality Research, United States.

How many publications and citations does Charudharshini Srinivasan have?

OpenAlex counts 28 works and 499 citations for Charudharshini Srinivasan, an h-index of 10, ranking #4,224,172 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Charudharshini Srinivasan. Posts are plain text and can be reported.